Choose your Region

Are you sure you want to proceed?

You will be leaving the Cook Medical website that you were viewing and going to a Cook Medical website for another region or country. Not all products are approved in all regulatory jurisdictions. The product information on these websites is intended only for licensed physicians and healthcare professionals.

May 10th, 2017

Cook Medical sells vertebroplasty product family to IZI Medical Products

Bloomington, Ind. – Cook Medical is pleased to announce the sale of its comprehensive family of vertebroplasty products to IZI Medical Products, LLC. This sale includes the Duro-Ject® Osteo-Site®, Osteo-Force® and Vertefix® brands in addition to other needles, injectors and cements. Moving this product family from Cook Medical to IZI Medical Products is a positive decision for both companies and for the patients impacted by spinal fractures.

“In the US, there’s an estimated 700,000 vertebral fractures a year due to osteoporosis1,” said Pete Yonkman, president of Cook Medical and Cook Group. “We were not giving this product family the resources it needed to continue to advance, so we’re pleased to have found it a new home with IZI Medical. The sale of our vertebroplasty product family allows us to concentrate on our primary product lines while allowing IZI Medical to focus on helping to treat patients suffering from spinal fractures.”

The vertebroplasty product family is used in the growing market for treating vertebral compression fractures through a minimally invasive procedure. IZI has planned a significant investment in a dedicated sales force, international distributor network, select product enhancements and new product development.

This product family is manufactured in Cook Medical’s Bloomington, Indiana, facility where many other products are built. This change will not impact that facility or its employees.

IZI Medical is the interventional products platform of Shore Capital Partners.

About Cook Medical
Since 1963 Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we are combining medical devices, biologic materials and cellular therapies to help the world’s healthcare systems deliver better outcomes more efficiently. We have always remained family owned so that we have the freedom to focus on what we care about: patients, our employees and our communities. Find out more at, and for the latest news, follow us on Twitter, Facebook and LinkedIn.

1 Ensrud KE, Schousboe JT. Clinical practice. Vertebral fractures. N Engl J Med. 2011;364(17):1634–1642.